Monday, Oct 24th

Last update05:20:13 AM GMT

You are here News Health FDA ignored debris in syringes

FDA ignored debris in syringes

E-mail Print PDF

Months before an Angier company shipped deadly bacteria-tainted drugs, the federal Food and Drug Administration received numerous complaints about sediment and debris in the medicine.

The FDA received reports about AM2PAT as early as 2005, but not until December 2007 did the agency issue recall notices to pull the drugs off the market.

Two men pleaded guilty in U.S. District Court this week for their roles in the scheme, which involved falsifying documents to make it appear that proper sterility tests had been conducted. The company’s president, Dushyant Patel, faces 10 charges, but he has not been arrested.


Most Recent Related Stories...

Americans overwhelmingly support abortion rights

Americans support abortion rightsPolitical candidates, consultants and the media generally misunderstand the politics of abortion rights. They tend to...

France to open first safe-injection room for drug addicts

safe heroin injection room opened in FranceFrance will open its first safe-injection room for drug addicts despite years of efforts by conservatives...

St. Jude warns of heart-device battery issue linked to two deaths

St. Jude'sSt. Jude Medical Inc warned on Tuesday that some of its implanted heart devices were at...

EpiPen maker Mylan to pay $465M to settle claims it overbilled Medicaid

Mylan to pay for Medicaid fraudEmbattled pharmaceutical company Mylan agreed Friday to pay nearly a half-billion dollars to settle claims that...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!